Novavax

This large, late-stage study is testing a new combination vaccine that aims to protect against both COVID-19 and the flu with a single shot. About 9,300 adults aged 65 and older will receive either the combo vaccine or a standard flu vaccine. Researchers will compare how well eac…

This study tests a single dose of a new COVID-19 vaccine designed to protect against the JN.1 variant. About 6,500 healthy adults aged 50 to 64 who are not at high risk for severe COVID will receive either the vaccine or a placebo. Researchers will track who gets sick with COVID …